Literature DB >> 23124806

Hyperpolarized helium-3 magnetic resonance imaging of chronic obstructive pulmonary disease exacerbation.

Miranda Kirby1, Nikhil Kanhere, Roya Etemad-Rezai, David G McCormack, Grace Parraga.   

Abstract

A chronic obstructive pulmonary disease (COPD) exsmoker underwent pulmonary function tests and hyperpolarized helium-3 ((3) He) magnetic resonance imaging (MRI) serially over 4 years, twice prior to and twice following an acute exacerbation (AE). About 2.5 years pre-AE, (3) He ventilation defect percent (VDP) was 16%, the apparent diffusion coefficient (ADC) was 0.34 cm(2) /s, and forced expiratory volume in 1 sec (FEV1 ) was 41%pred . Six months pre-AE, VDP and ADC were worse (29% and 0.38 cm(2) /s, respectively) without worsening FEV1 (47%pred ). After hospitalization and AE treatment, VDP was 20%, whereas FEV1 did not improve (45%pred ); 16 months post-AE, both VDP and ADC remained improved and similar to 4 years prior.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23124806     DOI: 10.1002/jmri.23896

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  8 in total

1.  Optically polarized 3He.

Authors:  T R Gentile; P J Nacher; B Saam; T G Walker
Journal:  Rev Mod Phys       Date:  2017-12-11       Impact factor: 54.494

2.  Assessment of pulmonary microstructural changes by hyperpolarized 129Xe diffusion-weighted imaging in an elastase-instilled rat model of emphysema.

Authors:  Ke Wang; Ting Pan; Hao Yang; Weiwei Ruan; Jianping Zhong; Guangyao Wu; Xin Zhou
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 3.  Magnetic resonance imaging with hyperpolarized agents: methods and applications.

Authors:  Erin B Adamson; Kai D Ludwig; David G Mummy; Sean B Fain
Journal:  Phys Med Biol       Date:  2017-04-06       Impact factor: 3.609

Review 4.  Pulmonary CT and MRI phenotypes that help explain chronic pulmonary obstruction disease pathophysiology and outcomes.

Authors:  Eric A Hoffman; David A Lynch; R Graham Barr; Edwin J R van Beek; Grace Parraga
Journal:  J Magn Reson Imaging       Date:  2015-07-22       Impact factor: 4.813

5.  Multi-scale analysis of imaging features and its use in the study of COPD exacerbation susceptible phenotypes.

Authors:  Felix J S Bragman; Jamie R McClelland; Marc Modat; Sébastien Ourselint; John R Hurst; David J Hawkes
Journal:  Med Image Comput Comput Assist Interv       Date:  2014

6.  129Xe MRI ventilation defects in ever-hospitalised and never-hospitalised people with post-acute COVID-19 syndrome.

Authors:  Harkiran K Kooner; Marrissa J McIntosh; Alexander M Matheson; Carmen Venegas; Nisarg Radadia; Terence Ho; Ehsan Ahmed Haider; Norman B Konyer; Giles E Santyr; Mitchell S Albert; Alexei Ouriadov; Mohamed Abdelrazek; Miranda Kirby; Inderdeep Dhaliwal; J Michael Nicholson; Parameswaran Nair; Sarah Svenningsen; Grace Parraga
Journal:  BMJ Open Respir Res       Date:  2022-05

Review 7.  Functional imaging of the lungs with gas agents.

Authors:  Stanley J Kruger; Scott K Nagle; Marcus J Couch; Yoshiharu Ohno; Mitchell Albert; Sean B Fain
Journal:  J Magn Reson Imaging       Date:  2015-07-27       Impact factor: 4.813

Review 8.  Thoracic Imaging at Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review.

Authors:  Bojidar A Rangelov; Alexandra L Young; Joseph Jacob; Anthony P Cahn; Sarah Lee; Frederick J Wilson; David J Hawkes; John R Hurst
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.